Transplantation of mesenchymal stem cells inhibits lymphocyte cytotoxic activity against cardiac myocytes after myocardial infarction

DU Youyou,ZHOU Shenghua,ZHOU Tao,SU Hua,DU Wanhong,PAN Hongwei

DOI: https://doi.org/10.3969/j.issn.1001-1439.2007.10.024

2007-01-01

Journal of Clinical Cardiology

Abstract:Objective:To investigate whether mesenchymal stem cells(MSCs)could inhibit lymphocyte cytotoxic activity against cardiac myocytes after myocardial infarction(MI).Method:SD rats were subjected to MI by left coronary artery occlusion.MSCs or PBS was injected into MI rats from epicardium instantly.In addition,normal and sham-AMI rats were made as control groups.Splenocytes were abstracted at 1,2 and 4 weeks after MI and were cultivated with cardiac myocytes of neonate rats.Lymphocyte cytotoxic activity against cardiac myocytes was detected by crystal-violet staining assay.Result:After MI,cytotoxic activity of PBS groups at 2 and 4 weeks[(32.31±7.23)%,(47.20±5.13)%] was higher than normal groups[(21.95±4.65)%,(22.13±5.08)%] and sham-AMI groups([22.21±5.43]%,[24.21±5.40]%)Compared with PBS groups,MSCs inhibited the cytotoxic activity in some extent([26.14±5.15]%,[34.28±6.13]%).Conclusion:MSCs transplantation can inhibit the cytotoxic activity of lymphocyte from splenocytes in rats with MI.